EUVIMEDEUVIMED entdecken
Crossref

Contrast enhanced ultrasound at first month: A feasible predictor for retreatment after benign thyroid nodule thermal ablation

Tinghui Yin, Yifei Leng, Bowen Zheng, Jinfen Wang, Lei Tan, Yuting He, Yufan Lian, Yanping Ma, Ge Tong, Xiuling Chen, Tao Wu, Jie Ren

European Journal of Radiology · 2026

DOI: 10.1016/j.ejrad.2025.112628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Radiology, 2026. Verfasst von Tinghui Yin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasonic, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. Hauptthemen laut MEDLINE: Thyroid Nodule. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Sun Yat-sen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To determine the clinical values of contrast enhanced ultrasound (CEUS) at the first follow-up for predicting retreatment in benign thyroid nodules (BTNs) after thermal ablation (TA). MATERIALS AND METHODS: A total of 176 BTNs from 155 patients who underwent TA with a median follow-up period of 32.5 months (range 7 to 83 months) were enrolled in this study. Initial ablation ratio (IAR) and CEUS base IAR (CIAR) was calculated by conventional US and CEUS at 1-month after TA. The predicting performances for retreatment of quantitative and qualitative CEUS at 1-month after TA were analyzed by receiver operating characteristic (ROC) curves and Kaplan-Meier survival analysis. RESULTS: The median final volume reduction rate (VRR) of all nodules was 96.9% (range 31.4% to 100%). The areas under curves (AUCs) of quantitative and qualitative CEUS at 1-month for nodular retreatment were 0.986 and 0.981. Correspondingly, the sensitivity, negative predictive value (NPV) and negative likelihood ratio (LR) were 100%, 100% and 0 for both quantitative and qualitative CEUS. CONCLUSION: CEUS at 1-month is a feasible predictor for nodular retreatment after BTNs TA. According to our results, CEUS is recommended as routine at the first follow-up for BTNs underwent TA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NoduleHumansFemaleContrast MediaUltrasonographyTreatment OutcomeSensitivity and SpecificityMaleAdultReproducibility of ResultsMiddle AgedAgedFeasibility StudiesRetreatmentYoung Adult

Stichwörter der Autor:innen

Benign thyroid nodulesContrast enhanced ultrasoundFollow-upRetreatmentThermal ablation

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Medical Ultrasonic, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
  • Department of Medical Ultrasonic, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. Electronic address: renj@mail.sysu.edu.cn.

Förderung

  • Sun Yat-sen University

Zitieren

APA

Yin, T., Leng, Y., Zheng, B., Wang, J., Tan, L., He, Y., Lian, Y., Ma, Y., Tong, G., Chen, X., Wu, T., & Ren, J. (2026). Contrast enhanced ultrasound at first month: A feasible predictor for retreatment after benign thyroid nodule thermal ablation. European Journal of Radiology. https://doi.org/10.1016/j.ejrad.2025.112628

Vancouver

Yin T, Leng Y, Zheng B, Wang J, Tan L, He Y, et al. Contrast enhanced ultrasound at first month: A feasible predictor for retreatment after benign thyroid nodule thermal ablation. European Journal of Radiology. 2026. doi:10.1016/j.ejrad.2025.112628

BibTeX
@article{Yin2026,
  author = {Yin, Tinghui and Leng, Yifei and Zheng, Bowen and Wang, Jinfen and Tan, Lei and He, Yuting and Lian, Yufan and Ma, Yanping and Tong, Ge and Chen, Xiuling and Wu, Tao and Ren, Jie},
  title = {Contrast enhanced ultrasound at first month: A feasible predictor for retreatment after benign thyroid nodule thermal ablation},
  journal = {European Journal of Radiology},
  year = {2026},
  doi = {10.1016/j.ejrad.2025.112628}
}
Kostenlos starten →